
Feb 23, 2026
2 minutes
Texas Medicaid Announces Reimbursement Rate Changes Effective March 1, 2026
The Texas Medicaid & Healthcare Partnership (TMHP) has announced reimbursement rate changes and updates for specific Medicaid procedure codes, effective for dates of service on or after March 1, 2026.
The following topics were covered at the November 10, 2025, public rate hearing:
Calendar Fee Review for the following:
- Allergy Testing
- Auditory System Surgery
- Blood Products
- Clinical Laboratory Services
- Clinical Diagnostic Laboratory Services - Gapfill
- Ear, Nose, and Throat
- Female Genital System Surgery
- Hearing Aids
- Intravenous Treatment Including Chemotherapy
- Male Genital System Surgery
- Musculoskeletal System Surgery
- Nuclear Medicine
- Nuclear Medicine Hospitals
- Nuclear Medicine - Rural Hospitals
- Orthotic and Prosthetics
- Outpatient Behavioral Health
- Physician Administered Drugs – Oncology
- Physician Administered Drugs - Vaccines & Toxoids
- Physician Administered Drugs – NDCX
- Pulmonary Services
- Radiation Oncology
- Radiation Oncology-Hospitals
- Substance Use Disorder Services
- Q Codes
- Q Codes - TOS 9, J, L
- Q Codes – Drugs
- Q Codes - Hospital Outpatient Imaging
- Q Codes - Rural Hospital Outpatient Imaging
- Radiopharmaceuticals
First Quarter 2025 Healthcare Common Procedure Coding System (HCPCS) Review for the following:
- Drugs
- Durable Medical Equipment TOS 9-J-L
- Radiology TOS 4-I-T
- Radiology TOS 4-I-T Hospitals
- Radiology TOS 4-I-T Rural Hospitals
Second Quarter 2025 HCPCS Review for the following:
Medical Policy
If you have questions, call 800-568-2413.
























